Evolution of Cutaneous Hidradenocarcinoma: A Clinicopathologic and Genomic Study of 8 Cases
2022
Fellows' Presentations
(200) TYK2-rearranged primary cutaneous T-cell lymphoma/lymphoproliferative disorder with novel (variant) fusion partners appear distinct from NPM1::TYK2 fusion positive CD30+ lymphoproliferative disorders
Posters
2024
Poster Defense Session and Mentorship Awards (hidden)
(178) Pathologic features of mycosis fungoides with JAK2 fusions; a case series
Posters
Poster
2024
Poster Defense Session and Mentorship Awards (hidden)
(198) Utility of fluorescence in situ hybridization to detect JAK family fusions in cutaneous T-cell lymphoma/lymphoproliferative disorders
Posters
Poster
2024
Poster Defense Session and Mentorship Awards (hidden)
TRBC1 Immunohistochemistry and Tissue Flow Cytometry in the Evaluation of Mogamulizumab-associated Rash
Plenary (virtual)
2024
Oral Abstract Session 1
NUT Adnexal Carcinoma with Delayed Lung Metastasis
Plenary (In-person & live-streamed)
Attachment
2025
Oral Abstract Session 1
(184) JAK2 Rearrangements in Primary Cutaneous CD30+ Lymphoproliferative Disorders
Posters (Non-CME)
Poster
2025
Poster Defense and Mentorship Awards
(187) TCRα, CD3 and TCRβ Differ in TRBC1-based Clonality Assessment of CD30+ Lymphoproliferative Disorders
Posters (Non-CME)
Poster
2025
Poster Defense and Mentorship Awards
(VIRTUAL) Duodenal well differentiated neuroendocrine neoplasm, esophageal papillomatosis, and parotid basal cell adenomas in the context of HRAS G13R-associated phacomatosis pigmentokeratotica provide a new link to sporadic systemic HRAS driven tumors
Posters (Non-CME)
Poster
2025
Poster Defense and Mentorship Awards